a Phase I PK Study in Healthy Male Subjects. 2 Groups of Healthy Male Subjects

NCT07166796 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Health Subjects

Interventions

DRUG: singe dose 15mg
DRUG: single dose 30mg
DRUG: single dose 60mg
DRUG: single dose 120mg
DRUG: multi dose 30mg
DRUG: multi dose 60mg

Sponsor

Otsuka Beijing Research Institute

Collaborators

[object Object]